Pursue Wealth Partners’s Eli Lilly LLY Stock Holding History

Pursue Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Sell	1,304 -824	-39%	-$842K	0.88%	38
2026 Q1	$1.96M	Sell	2,128 -8	-0.4%	-$8.11K	1.17%	27
2025 Q4	$2.3M	Buy	+2,136	New	+$2.04M	1.12%	27
2025 Q1	–	Sell	-579	Closed	-$447K	–	126
2024 Q4	$447K	Buy	579 +168	+41%	+$139K	0.26%	63
2024 Q3	$364K	Buy	+411	New	+$370K	0.2%	70
2022 Q2	–	Sell	-91	Closed	-$28.1K	–	175
2022 Q1	$28.1K	Buy	+91	New	+$23.4K	0.01%	198

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pursue Wealth Partners's LLY Position: Q2 2026 in Review

Pursue Wealth Partners reduced its Eli Lilly (LLY) stake by 39% in Q2 2026, selling an estimated $842K and leaving 1,304 shares worth $1.56M. The position accounts for 0.88% of the portfolio, ranked #38.

Pursue Wealth Partners first reported a position in LLY in Q1 2022 and has held it in 6 quarters since. The position peaked at $2.3M in Q4 2025. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Pursue Wealth Partners held 1,304 shares of Eli Lilly worth $1.56M as of Q2 2026.
Pursue Wealth Partners sold 824 Eli Lilly shares in Q2 2026, an estimated $842K.
Eli Lilly made up 0.88% of Pursue Wealth Partners's portfolio in Q2 2026, its #38 holding.
Pursue Wealth Partners first reported a position in Eli Lilly in Q1 2022 and has held it in 6 quarters since.
Pursue Wealth Partners's Eli Lilly position peaked at $2.3M in Q4 2025.
4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pursue Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.